Quarter Financials
Interpace Biosciences, Inc. (IDXG)
$1.18
0.00 (0.00%)
Income Statement
Balance Sheet
Cash Flow
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
Net Income | -14 | -4 | -2 | -4 | -4 | -3 | -4 | -8 |
Dividend Paid | - | - | - | - | - | - | - | - |
Retained Earnings | -247 | -233 | -229 | -227 | -223 | -220 | -216 | -212 |
---|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
Capital Expenditure | -0 | -0 | -0 | -0 | -0 | - | - | -0 |
Net PPE | 1 | 9 | 10 | 10 | 10 | 11 | 11 | 12 |
---|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
New Purchases | - | - | - | - | - | - | - | - |
Intangible and Goodwill | 8 | 8 | 8 | 8 | 8 | 8 | 8 | - |
---|